Study on AhR showed that it can be a potential drug target for estrogen receptor (ER)-positive breast cancer and relatively non-toxic 6-methyl-1,3,8-trichlorodibenzofuran (MCDF) is a highly valuable agent to inhibit hormone responsive breast cancer growth in animal models [5]. The gene discussed is ESR1; the disease is breast cancer.